Microglial Immunoreceptor Tyrosine-based Activation and Inhibition Motif Signaling in Neuroinflammation

Overview

Journal Int J Alzheimers Dis

Publisher Wiley

Date 2010 Aug 20

PMID 20721346

Citations 50

Authors

Bettina Linnartz

Yiner Wang

Harald Neumann

Affiliations

Soon will be listed here.

Abstract

Elimination of extracellular aggregates and apoptotic neural membranes without inflammation is crucial for brain tissue homeostasis. In the mammalian central nervous system, essential molecules in this process are the Fc receptors and the DAP12-associated receptors which both trigger the microglial immunoreceptor tyrosine-based activation motif- (ITAM-) Syk-signaling cascade. Microglial triggering receptor expressed on myeloid cells-2 (TREM2), signal regulatory protein-beta1, and complement receptor-3 (CD11b/CD18) signal via the adaptor protein DAP12 and activate phagocytic activity of microglia. Microglial ITAM-signaling receptors are counter-regulated by immunoreceptor tyrosine-based inhibition motif- (ITIM-) signaling molecules such as sialic acid-binding immunoglobulin superfamily lectins (Siglecs). Siglecs can suppress the proinflammatory and phagocytic activity of microglia via ITIM signaling. Moreover, microglial neurotoxicity is alleviated via interaction of Siglec-11 with sialic acids on the neuronal glycocalyx. Thus, ITAM- and ITIM-signaling receptors modulate microglial phagocytosis and cytokine expression during neuroinflammatory processes. Their dysfunction could lead to impaired phagocytic clearance and neurodegeneration triggered by chronic inflammation.

Citing Articles

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease.

Western D, Timsina J, Wang L, Wang C, Yang C, Phillips B Nat Genet. 2024; 56(12):2672-2684.

PMID: 39528825 PMC: 11831731. DOI: 10.1038/s41588-024-01972-8.

Biological function of sialic acid and sialylation in human health and disease.

Zhu W, Zhou Y, Guo L, Feng S Cell Death Discov. 2024; 10(1):415.

PMID: 39349440 PMC: 11442784. DOI: 10.1038/s41420-024-02180-3.

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.

Wissfeld J, Abou Assale T, Cuevas-Rios G, Liao H, Neumann H Front Neurol. 2024; 15:1330874.

PMID: 38529039 PMC: 10961342. DOI: 10.3389/fneur.2024.1330874.

HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signaling.

Wong E, Malviya M, Jain T, Liao G, Kehs Z, Chang J Mol Psychiatry. 2024; 29(7):2084-2094.

PMID: 38383769 PMC: 11336028. DOI: 10.1038/s41380-024-02474-z.

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's disease.

Cruchaga C, Western D, Timsina J, Wang L, Wang C, Yang C Res Sq. 2023; .

PMID: 37333337 PMC: 10275048. DOI: 10.21203/rs.3.rs-2814616/v1.

References

Nimmerjahn F, Ravetch J . Fc-receptors as regulators of immunity. Adv Immunol. 2007; 96:179-204. DOI: 10.1016/S0065-2776(07)96005-8. View

Lu J, Wu X, Teh B . The regulatory roles of C1q. Immunobiology. 2007; 212(4-5):245-52. DOI: 10.1016/j.imbio.2006.11.008. View

Chouery E, Delague V, Bergougnoux A, Koussa S, Serre J, Megarbane A . Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum Mutat. 2008; 29(9):E194-204. DOI: 10.1002/humu.20836. View

Wakselman S, Bechade C, Roumier A, Bernard D, Triller A, Bessis A . Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci. 2008; 28(32):8138-43. PMC: 6670768. DOI: 10.1523/JNEUROSCI.1006-08.2008. View

Reichwald J, Danner S, Wiederhold K, Staufenbiel M . Expression of complement system components during aging and amyloid deposition in APP transgenic mice. J Neuroinflammation. 2009; 6:35. PMC: 2784442. DOI: 10.1186/1742-2094-6-35. View

Maier M, Peng Y, Jiang L, Seabrook T, Carroll M, Lemere C . Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci. 2008; 28(25):6333-41. PMC: 3329761. DOI: 10.1523/JNEUROSCI.0829-08.2008. View

Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, Mork S . Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J Neurol Sci. 1994; 121(2):125-31. DOI: 10.1016/0022-510x(94)90340-9. View

Hu S, Chao C, Ehrlich L, Sheng W, Sutton R, Rockswold G . Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J Leukoc Biol. 1999; 65(6):815-21. DOI: 10.1002/jlb.65.6.815. View

Daws M, Sullam P, Niemi E, Chen T, Tchao N, Seaman W . Pattern recognition by TREM-2: binding of anionic ligands. J Immunol. 2003; 171(2):594-9. DOI: 10.4049/jimmunol.171.2.594. View

10.

Kielian T . Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res. 2006; 83(5):711-30. PMC: 2440498. DOI: 10.1002/jnr.20767. View

11.

Crocker P, Paulson J, Varki A . Siglecs and their roles in the immune system. Nat Rev Immunol. 2007; 7(4):255-66. DOI: 10.1038/nri2056. View

12.

Stewart C, Stuart L, Wilkinson K, van Gils J, Deng J, Halle A . CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2009; 11(2):155-61. PMC: 2809046. DOI: 10.1038/ni.1836. View

13.

Takahashi K, Rochford C, Neumann H . Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005; 201(4):647-57. PMC: 2213053. DOI: 10.1084/jem.20041611. View

14.

Paloneva J, Kestila M, Wu J, Salminen A, Bohling T, Ruotsalainen V . Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000; 25(3):357-61. DOI: 10.1038/77153. View

15.

Hanisch U, Kettenmann H . Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007; 10(11):1387-94. DOI: 10.1038/nn1997. View

16.

Colonna M . TREMs in the immune system and beyond. Nat Rev Immunol. 2003; 3(6):445-53. DOI: 10.1038/nri1106. View

17.

Liu Y, Walter S, Stagi M, Cherny D, Letiembre M, Schulz-Schaeffer W . LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain. 2005; 128(Pt 8):1778-89. DOI: 10.1093/brain/awh531. View

18.

Grathwohl S, Kalin R, Bolmont T, Prokop S, Winkelmann G, Kaeser S . Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci. 2009; 12(11):1361-3. PMC: 4721582. DOI: 10.1038/nn.2432. View

19.

Garcia-Garcia E, Rosales C . Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol. 2002; 72(6):1092-108. View

20.

Bard F, Cannon C, Barbour R, Burke R, Games D, Grajeda H . Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000; 6(8):916-9. DOI: 10.1038/78682. View